Jane E Joseph1, Aimee McRae-Clark2,3, Brian J Sherman2, Nathaniel L Baker4, Megan Moran-Santa Maria2, Kathleen T Brady2,3. 1. Department of Neuroscience, Medical University of South Carolina, 96 Jonathan Lucas St., Clinical Sciences Building Room 325E, Charleston, SC, 29425, USA. josep@musc.edu. 2. Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, 96 Jonathan Lucas St., Clinical Sciences Building Room 325E, Charleston, SC, 29425, USA. 3. Ralph H. Johnson VA Medical Center, Charleston, SC, USA. 4. Department of Public Health Sciences, Medical University of South Carolina, 96 Jonathan Lucas St., Clinical Sciences Building Room 325E, Charleston, SC, 29425, USA.
Abstract
RATIONALE: Women with cocaine use disorder have worse treatment outcomes compared with men. Sex differences in cocaine addiction may be driven by differences in neurobiology or stress reactivity. Oxytocin is a potential therapeutic for stress reduction in substance use disorders, but no studies have examined the effect of oxytocin on neural response to drug cues in individuals with cocaine use disorders or potential sex differences in this response. OBJECTIVES: The goal of this study was to examine the effect of intranasal oxytocin on cocaine cue reactivity in cocaine dependence, modulated by gender and history of childhood trauma. METHODS: Cocaine-dependent men with (n = 24) or without (n = 19) a history of childhood trauma and cocaine-dependent women with (n = 16) or without (n = 8) a history of childhood trauma completed an fMRI cocaine cue reactivity task under intranasal placebo or oxytocin (40 IU) on two different days. fMRI response was measured in the right amygdala and dorsomedial prefrontal cortex (DMPFC). RESULTS: In the DMPFC, oxytocin reduced fMRI response to cocaine cues across all subject groups. However, in the amygdala, only men with a history of childhood trauma showed a significantly reduced fMRI response to cocaine cues on oxytocin versus placebo, while women with a history of childhood trauma showed an enhanced amygdala response to cocaine cues following oxytocin administration. Cocaine-dependent subjects with no history of childhood trauma showed no effect of oxytocin on amygdala response. CONCLUSIONS: Oxytocin can reduce cue reactivity in cocaine dependence, but its effect is modified by sex and childhood trauma history. Whereas men with cocaine dependence may benefit from oxytocin administration, additional studies are needed to determine whether oxytocin can be an effective therapeutic for cocaine-dependent women.
RATIONALE: Women with cocaine use disorder have worse treatment outcomes compared with men. Sex differences in cocaine addiction may be driven by differences in neurobiology or stress reactivity. Oxytocin is a potential therapeutic for stress reduction in substance use disorders, but no studies have examined the effect of oxytocin on neural response to drug cues in individuals with cocaine use disorders or potential sex differences in this response. OBJECTIVES: The goal of this study was to examine the effect of intranasal oxytocin on cocaine cue reactivity in cocaine dependence, modulated by gender and history of childhood trauma. METHODS: Cocaine-dependent men with (n = 24) or without (n = 19) a history of childhood trauma and cocaine-dependent women with (n = 16) or without (n = 8) a history of childhood trauma completed an fMRI cocaine cue reactivity task under intranasal placebo or oxytocin (40 IU) on two different days. fMRI response was measured in the right amygdala and dorsomedial prefrontal cortex (DMPFC). RESULTS: In the DMPFC, oxytocin reduced fMRI response to cocaine cues across all subject groups. However, in the amygdala, only men with a history of childhood trauma showed a significantly reduced fMRI response to cocaine cues on oxytocin versus placebo, while women with a history of childhood trauma showed an enhanced amygdala response to cocaine cues following oxytocin administration. Cocaine-dependent subjects with no history of childhood trauma showed no effect of oxytocin on amygdala response. CONCLUSIONS: Oxytocin can reduce cue reactivity in cocaine dependence, but its effect is modified by sex and childhood trauma history. Whereas men with cocaine dependence may benefit from oxytocin administration, additional studies are needed to determine whether oxytocin can be an effective therapeutic for cocaine-dependent women.
Entities:
Keywords:
Amygdala; Cocaine use disorder; Functional magnetic resonance imaging; Prefrontal cortex; Sex differences
Authors: Anita C Hansson; Anne Koopmann; Stefanie Uhrig; Sina Bühler; Esi Domi; Eva Kiessling; Roberto Ciccocioppo; Robert C Froemke; Valery Grinevich; Falk Kiefer; Wolfgang H Sommer; Sabine Vollstädt-Klein; Rainer Spanagel Journal: Neuropsychopharmacology Date: 2017-11-01 Impact factor: 7.853
Authors: James J Prisciandaro; Jane E Joseph; Hugh Myrick; Aimee L McRae-Clark; Scott Henderson; James Pfeifer; Kathleen T Brady Journal: Addiction Date: 2014-07-21 Impact factor: 6.526
Authors: D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar Journal: J Clin Psychiatry Date: 1998 Impact factor: 4.384
Authors: Jane E Joseph; Brandon K Vaughan; Christopher C Camp; Nathaniel L Baker; Brian J Sherman; Megan Moran-Santa Maria; Aimee McRae-Clark; Kathleen T Brady Journal: Front Psychiatry Date: 2019-07-19 Impact factor: 4.157
Authors: Caitlyn O Hood; Rachel L Tomko; Nathaniel L Baker; Breanna M Tuck; Julianne C Flanagan; Matthew J Carpenter; Kevin M Gray; Michael E Saladin; Erin A McClure Journal: Psychoneuroendocrinology Date: 2020-06-10 Impact factor: 4.905
Authors: Brian J Sherman; Nathaniel L Baker; Kathleen T Brady; Jane E Joseph; Lisa M Nunn; Aimee McRae-Clark Journal: Psychopharmacology (Berl) Date: 2020-05-09 Impact factor: 4.530
Authors: Lauren M Sippel; Julianne C Flanagan; Paul E Holtzheimer; Megan M Moran-Santa-Maria; Kathleen T Brady; Jane E Joseph Journal: Psychiatry Res Neuroimaging Date: 2021-08-20 Impact factor: 2.376
Authors: Heather E Webber; Danielle A Kessler; Emma C Lathan; Margaret C Wardle; Charles E Green; Joy M Schmitz; Scott D Lane; Anka A Vujanovic Journal: Drug Alcohol Depend Date: 2021-07-28 Impact factor: 4.852